Skip to main content

Interventional Cardiology

Coronary Therapies

The medical device industry’s most complete portfolio of PCI products

Together we can strengthen quality outcomes, increase operational efficiencies, and improve financial health in your cardiovascular service line (CVSL).


Of all U.S. PCI patients present with calcium


Of all U.S. PCIs are complex


Higher reimbursement for complex PCI vs. standard PCI**

Medical professional helping a paitent in a wheelchair down a hallway.

If complex PCI is a focus, we can help. As a category leader in Interventional Cardiology, Boston Scientific brings the most comprehensive portfolio of PCI products, education programs, and healthcare solutions and partnerships. Work with us to:

A category leader in coronary therapies

An enlargement of the SYNERGY XD device

SYNERGY™ Bioabsorbable Polymer (BP) Stent Systems

Putting the patient first, we offer all the products, programs and solutions designed to help your CVSL strengthen quality outcomes, increase operational efficiencies, and improve financial health.

Leading on Studying Short DAPT

The SYNERGY BP Stent is indicated for use in high bleeding risk patients with short DAPT labeling. Boston Scientific is leading the way in supporting short DAPT studies with the SYNERGY BP Stent in a variety of patient populations and DAPT durations.

.0% ST

0-month DAPT
ASET Trial

3 months post PCI

.0% ST

1 month DAPT

From 1-12 months

.9% ST

1 month DAPT
POEM Trial

At 1 year

.2% ST

3 month DAPT

From 3-15 months

A full portfolio built for modern PCI

SYNTAX II trial utilizes contemporary PCI tools and techniques producing CABG-like outcomes.

Tools to see, prep, and treat because no two patients are the same.

Drug-Eluting Therapies

SYNERGY™ XD Stent System
Equipped with an innovative delivery system designed to make optimal healing even more deliverable

Closeup of AGENT Drug-Coated Balloon

AGENT™ Drug-Coated Balloon
A new treatment option for patients with in-stent restenosis (ISR)

Purpose-built DES for large proximal vessels

PCI Guidance

Computer screen showing Boston Scientific's AVIGGO +

Multi-Modality Guidance System

FFR Pressure Guidewire

Imaging Catheters

Complex PCI

Rotational Atherectomy System

Closeup of WOLVERIN CoroEnary Cutting Balloon

Coronary Cutting Balloon™

PTCA Dilatation Catheter

Coronary therapies resources

Coding and payment guides

Find additional information on coding, payment guides, and reimbursement information for inpatient, outpatient, office, and ASC settings.

Practical solutions for complex challenges

Boston Scientific is offering a growing selection of offerings specifically tailored to propel your cardiovascular business forward.

Contact Us

Get in touch with a sales representative to discuss how our portfolio of product and solutions can deliver measurable outcomes in the cardiovascular service line.


**CY2021 CMS national base rate is $16,064 for APC 5194 vs. $10,043 for APC 5193. Actual rates will vary geographically and/or by individual facility
1. Presented by Pedro Lemos, MD at TCT2019
2. Kogame N, et al. J Am Coll Cardiol Intv. 2020;13:2251-62. DOI: 10.1016/j.jcin.2020.06.023
3. Presented by Giulio Stefanini, MD at EuroPCR 2021. This study evaluated the safety of the SYNERGY BP Stent with 1-month DAPT in high bleeding risk (HBR) patients
4. Pivato C.A., et al. J Am Heart Assoc. 2022;11:e023454. DOI: 10.1161/JAHA.121.023454
5. The SYNERGY BP Stent HBR indication is supported by the EVOLVE Short DAPT data. The HBR indication excludes SYNERGY XD 48 mm